Company Information & Drug Savings for Alvotech and Teva Pharmaceuticals Medications
Alvotech, in partnership with Teva Pharmaceuticals, develops and commercializes high-quality biosimilar medications. The collaboration focuses on bringing affordable biosimilar alternatives to expensive biologic drugs, including treatments for autoimmune diseases, oncology, and ophthalmology. Products include AVT02, a biosimilar to Humira (adalimumab). The partnership aims to increase patient access to life-changing biologic therapies through cost-effective biosimilar options.


How to Contact Alvotech and Teva Pharmaceuticals
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.




